These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

539 related articles for article (PubMed ID: 25510165)

  • 1. Short- and long-term outcomes after silastic medicalization laryngoplasty: are arytenoid procedures needed?
    Benninger MS; Manzoor N; Ruda JM
    J Voice; 2015 Mar; 29(2):236-40. PubMed ID: 25510165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Novel Endoscopic Arytenoid Medialization for Unilateral Vocal Fold Paralysis.
    Rovó L; Ambrus A; Tóbiás Z; Wootten CT; Bach Á
    Laryngoscope; 2021 Mar; 131(3):E903-E910. PubMed ID: 32790084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics of the Voice Handicap Index for Patients With Unilateral Vocal Fold Paralysis Who Underwent Arytenoid Adduction.
    Watanabe K; Sato T; Honkura Y; Kawamoto-Hirano A; Kashima K; Katori Y
    J Voice; 2020 Jul; 34(4):649.e1-649.e6. PubMed ID: 30616964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel approach of medialization thyroplasty with arytenoid adduction performed under general anesthesia with a laryngeal mask.
    Stow NW; Lee JW; Cole IE
    Otolaryngol Head Neck Surg; 2012 Feb; 146(2):266-71. PubMed ID: 22075075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short-term treatment results for unilateral vocal fold palsy induced by mediastinal lesions.
    Lee YS; Kim YH; Kwon M; Ryu IS; Jung GE; Kim ST; Roh JL; Choi SH; Kim SY; Nam SY
    J Voice; 2014 Nov; 28(6):809-15. PubMed ID: 25008380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Voice outcomes following medialization laryngoplasty with and without arytenoid adduction.
    Zimmermann TM; Orbelo DM; Pittelko RL; Youssef SJ; Lohse CM; Ekbom DC
    Laryngoscope; 2019 Aug; 129(8):1876-1881. PubMed ID: 30582612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medialization Laryngoplasty After Injection Augmentation.
    Silva Merea V; Husain S; Sulica L
    J Voice; 2018 Mar; 32(2):249-255. PubMed ID: 28684252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of pitch range after arytenoid adduction by fenestration approach combined with type I thyroplasty for unilateral vocal fold paralysis.
    Tokashiki R; Hiramatsu H; Shinada E; Motohashi R; Nomoto M; Toyomura F; Suzuki M
    J Voice; 2012 Nov; 26(6):792-6. PubMed ID: 22417985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arytenoid adduction combined with medialization laryngoplasty under general anesthesia using a laryngeal mask airway.
    Kanazawa T; Watanabe Y; Hara M; Shinnabe A; Kusaka G; Murayama T; Iino Y
    Am J Otolaryngol; 2012; 33(3):303-7. PubMed ID: 21962288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arytenoid adduction combined with nerve-muscle pedicle flap implantation or type I thyroplasty.
    Kodama N; Kumai Y; Sanuki T; Yumoto E
    Laryngoscope; 2017 Jan; 127(1):159-166. PubMed ID: 27112111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Laryngoplasty with hyaluronic acid in patients with unilateral vocal fold paralysis.
    Reiter R; Brosch S
    J Voice; 2012 Nov; 26(6):785-91. PubMed ID: 22578435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arytenoid vertical height discrepancy in predicting outcomes after unilateral vocal cord medialization.
    Wong E; Smith M; Stone DB; Palme CE; Smith MC; Riffat F
    Laryngoscope; 2020 Feb; 130(2):418-422. PubMed ID: 30843620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Injection versus medialization laryngoplasty for the treatment of unilateral vocal fold paralysis: follow-up at six months.
    Vinson KN; Zraick RI; Ragland FJ
    Laryngoscope; 2010 Sep; 120(9):1802-7. PubMed ID: 20641088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Sequentially Combined Arytenoid Adduction and Injection Laryngoplasty in Patients With Unilateral Vocal Fold Paralysis.
    Choi N; Kim Y; Song BH; Koh SM; Park W; Kim HJ; Son YI
    J Voice; 2022 Nov; 36(6):868-873. PubMed ID: 33097366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of pitch range evaluation subsequent to arytenoid adduction and thyroplasty.
    Konomi U; Watanabe Y; Komazawa D
    J Voice; 2014 May; 28(3):394.e5-12. PubMed ID: 24345604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes of medialization laryngoplasty with and without arytenoid adduction.
    Chang J; Schneider SL; Curtis J; Langenstein J; Courey MS; Yung KC
    Laryngoscope; 2017 Nov; 127(11):2591-2595. PubMed ID: 28699172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of temporary vocal fold injection medialization on the rate of permanent medialization laryngoplasty in unilateral vocal fold paralysis patients.
    Yung KC; Likhterov I; Courey MS
    Laryngoscope; 2011 Oct; 121(10):2191-4. PubMed ID: 21898421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Custom implants for medialization laryngoplasty: a model that considers tissue compression.
    Benninger MS; Chota RL; Bryson PC; Drake RL
    J Voice; 2015 May; 29(3):363-9. PubMed ID: 25920766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term voice outcomes of laryngeal framework surgery for unilateral vocal fold paralysis.
    Mes SD; Hendriksma M; Heijnen BJ; Goudsmit BFJ; Jansen JC; Langeveld APM; Sjögren EV
    Eur Arch Otorhinolaryngol; 2022 Apr; 279(4):1957-1965. PubMed ID: 34787700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Injection laryngoplasty outcomes in irradiated and nonirradiated unilateral vocal fold paralysis.
    Chang J; Courey MS; Al-Jurf SA; Schneider SL; Yung KC
    Laryngoscope; 2014 Aug; 124(8):1895-9. PubMed ID: 24473831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.